Dublin, July 20, 2021 (GLOBE NEWSWIRE) — The “Europe Anticoagulant Reversal Drug Market Forecast to 2027 – COVID-19 Impact and Regional Analysis by Product; End User” report has been added to ResearchAndMarkets.com’s offering. The anticoagulant reversal drug market in Europe is expected to grow from US$ 270.0 million in 2019 to US$ 655.4 million by 2027; it is estimated to grow at a CAGR of 12.4% from 2019 to 2027.

By A Silva